Abstract A truncated form of the Ti-plasmid virE2 gene from Agrobacterium tumefaciens strains C58 and A6, and A. vitis strain CG450 was transferred and expressed in somatic embryos of grapevine rootstocks 110 Richter (Vitis rupestris 9 V. berlandieri), 3309 Couderc (V. rupestris 9 V. riparia) and Teleki 5C (V. berlandieri 9 V. riparia) via Agrobacteriummediated transformation to confer resistance to crown gall disease. Transformation was confirmed in 98% of the 322 lines by enzyme-linked immunosorbent assay for the neomycin phosphotransferase II protein and 97% of 295 lines by polymerase chain reaction for the truncated virE2 transgene. Southern blot analysis revealed the insertion of truncated virE2 at one to three loci in a subset of seven transgenic 110 Richter lines. In vitro resistance screening assays based on inoculations of shoot internode sections showed reduced tumorigenicity and very small galls in 23 of 154 transgenic lines. Non-transformed controls had a 100% tumorigenicity rate with very large galls.
Introduction
Crown gall is a serious bacterial disease of grapevines worldwide. It is caused by A. vitis and to a lesser extent by A. tumefaciens (Pearson and Goheen 1988; Burr et al. 1990 ). Crown gall can cause significant losses by reducing vigor and yield (30-50%) (Schroth et al. 1988) . The infection process has been studied extensively Burr and Otten 1999) . Tumors form on canes, usually on the lower region of the trunk, near grafting sites. They are initiated following injuries caused by freezing temperatures (Burr and Katz 1984) . On young vines crown gall is particularly damaging and may cause death. The natural host range of A. vitis is restricted to grape. A. vitis survives systemically in vines and can be disseminated in symptomless propagation material. Several important grapevine rootstocks are susceptible to crown gall, among which 110 Richter (V. rupestris 9 V. berlandieri) and Teleki 5C (V. berlandieri 9 V. riparia), are highly susceptible (Stover et al. 1997; Sule and Burr 1998) .
Genetic engineering is an attractive approach to develop disease-resistant grapevine rootstocks. Several transgenic rootstock genotypes have been developed for resistance to viruses including V. rupestris cv. St. George, 110 Richter (Vitis rupestris 9 V. berlandieri), 41B (V. berlandieri 9 V. rupestris, 3309 Couderc (V. rupestris 9 V. riparia), Teleki 5C, V. riparia cv. Gloire de Montpellier (V. riparia) and 101-14 Millardet et de Grasset (V. riparia 9 V. rupestris) (Colova Tsolova et al. 2001 ). In the case of crown gall, transgenic V. riparia cv. Gloire de Montpellier lines expressing a truncated virE2 gene from A. tumefaciens strain C58 gene were generated (Xue et al. 1999) . A truncated virE2 construct lacking the 215 C-terminal amino acids was selected to confer resistance to crown gall disease in grapevine rootstocks based on a previous report showing reduced tumorgenicity in transgenic tobacco plants (Citovsky et al. 1994) . To expand on our early attempts to engineer resistance to crown gall disease (Holden et al. 2003; Xue et al. 1999) , we developed new grapevine rootstocks containing truncated virE2 constructs with the aim of achieving practical resistance to A. vitis. Here, we report the transformation of the grapevine rootstocks 110 Richter, 3309 Couderc and Teleki 5C with truncated virE2 constructs from A. tumefaciens strains C58 and A6, and from A. vitis strain CG450, and on the reaction of transgenic plants to infection by homologous and heterologous Agrobacterium strains.
Materials and methods

Construction of binary plasmid containing virE2 expression cassette
An Agrobacterium virE2 gene lacking the region coding for a single-stranded DNA binding domain, as previously described (Citovsky et al. 1992) , was engineered from A. tumefaciens strains C58 and A6 and from A. vitis CG450. The virE2 coding sequence from A. tumefaciens strain C58 (Hiroka et al. 1987) was amplified from its nopaline catabolic Ti-plasmid by polymerase chain reaction (PCR) with primers NOP-forward (5 0 TACTTACCATGGATCCGAAGG CCGAAGGC 3 0 ) corresponding to the 5 0 coding region of the gene and NOP-reverse (5 0 CTTGACCATGGC TATCGATTCTCGC CGGCGAACTC 3 0 ) hybridizing to nucleotide positions 1,000-1,020 of the gene to produce virE2-C58. Likewise, virE2-A6 was amplified by PCR from octopine catabolic Ti-plasmid from A. tumefaciens strain A6 (Winans et al. 1987 ) using the primer pair OCT-forward (5 0 TACTTACCATGG ATCTTTCTGGCAATGAG 3 0 ) corresponding to the 5 0 coding region of octopine virE2 and OCT-reverse (5 0 AGATTCCCATGGTCATC TATTTTCGCCAA CAAATTCCGCG 3 0 ) hybridizing to nucleotide positions 927-951 of the gene. The virE2 construct of A. vitis strain CG450 (Momol et al. 1998 ) was amplified by using primers NOP-forward and NOP-reverse. All the primers contained a NcoI site (underlined) to facilitate subsequent cloning. In addition, a translation stop codon (in bold) was incorporated into primers NOP-reverse and OCT-reverse to ensure translational termination of the truncated virE2 constructs. Thus, expression of chimeric virE2 yielded proteins lacking the single strand DNA binding region.
The three truncated virE2 PCR products were digested with NcoI and directly cloned into the NcoIrestricted plant expression vector pEPT8 (Ling et al. 1997) . The resulting plasmids were designated as pEPT8-virE2-C58, pEPT8-virE2-A6 and pEPT8-virE2-CG450. The virE2 gene expression was regulated by the Cauliflower mosaic virus (CaMV) 35S promoter and CaMV 35S 3 0 poly (A) signal. An Alfalfa mosaic virus (AIMV) leader sequence was placed upstream of the truncated virE2 gene for enhanced expression (Ling et al. 1997) . The expression cassette was excised from these plasmids with HindIII and ligated to the plant transformation vector pBIN19 (Bevan 1984 ) that was cut with the same restriction enzyme. The resulting vectors pBIN19-virE2-C58; pBIN19-virE2-A6 and pBIN19-virE2-CG450 (Fig. S1 ) were transferred to A. tumefaciens vir helper strain C58sZ707 by electroporation.
Plant material and anther cultures
Immature inflorescences of 110 Richter (V. rupestris 9 V. berlandieri), 3309 Couderc (V. riparia 9 V. rupestris) and Teleki 5C (V. berlandieri 9 V. riparia) were collected about 2 weeks before flowering. Anthers were dissected and cultured as described previously (Bouquet et al. 1982) . Anthers were isolated from sterilized flower buds when pollen mother cells were at the uninucleate (GP1) or binucleate (GP2) developmental stages and plated on full strength basal Murashige and Skoog (1962) (MS) medium at a density of 40 floral buds per Petri dish (diameter 9 cm) and incubated at 28°C in the dark.
Induction of somatic embryogenesis and plant development
Induction of somatic embryogenesis and subculturing of embryogenic calli was carried out on solid, full strength MS medium containing 20 g/l sucrose, 0.2 mg/l 6-benzyl-aminopurine (BAP) and 1.1 mg/l 2,4-dichlorophenoxyacetic acid (2,4-D) (induction medium) in the dark at 28°C (Krastanova et al. 1993 (Krastanova et al. , 1995 (Krastanova et al. , 2000 . The pH was adjusted to 5.7 and Noble agar was added to a final concentration of 8 g/l. Cultures were maintained by transferring clumps of embryos to induction medium at 20-day intervals for calli multiplication. After 30-45 days, only secondary calli were transferred to half-strength MS medium supplemented with 3.6 ml/l glycerol for embryo differentiation. After 3 weeks, cultures were transferred to solid MS medium containing 1 g/l casein hydrolysate and 3.6 ml/l glycerol for embryo elongation. After 1-2 months elongated hypocotyls were transferred to the woody plant medium (WPM) (McCown and Lloyd 1981) supplemented with 0.1 mg/l BAP, 3 g/l activated charcoal, and 15 g/l sucrose, and grown at 25°C with a 16 h photoperiod under cool fluorescent light at 54 lEm -2 s -1 to induce shoot and root formation. The pH of WPM was adjusted to 5.7 and 6 g/l Bacto agar (Sigma A-1296) was added for solidification. After 3-4 weeks, well-rooted and elongated plantlets were transplanted to Cornell potting mix (Boodley and Sheldrake 1982) and acclimatized to green house conditions following standard practices. After the first-year evaluation, plants were prepared for dormancy and then moved into storage at 4°C for 3 months. After dormancy, potted plants were pruned, fertilized and grown in the greenhouse for a second year evaluation.
Agrobacterium-mediated transformation and regeneration of putative transgenic grapevine rootstocks Embryogenic calli of 110 Richter, Teleki 5C and 3309 Couderc were infected with A. tumefaciens strain C58sZ707 carrying the binary construct pBin19-EPT8-VirE2-C58 or pBin19-EPT8-VirE2-A6 or pBin19-EPT8-VirE2-CG450. A single recombinant Agrobacterium colony was grown overnight in 30 ml LB medium with 50 mg/l kanamycin and 100 mg/l acetosyringone at 28°C. The culture was centrifuged at 3,0009g for 10 min and the pellet suspended in half-strength MS with 100 mg/l acetosyringone to an OD 600nm of 0.5-0.7. Homogenous early globular embryos were immersed in the Agrobacterium suspension for 20 min, briefly blotted on sterile Whatman filter paper and transferred onto MS (induction medium) in the dark at 25°C. After 2 days of co-cultivation, embryogenic calli were fragmented and transferred to selective MS medium supplemented with 25 mg/l kanamycin, 300 mg/l cefotaxime, 200 mg/l carbenicillin and 100 mg/l acetosyringone in 90 mm plates. Calli were cultured at 28°C in the dark with subculturing every 20 days. After the first 3 weeks of culture, acetosyringone was not used anymore. After 6-8 weeks, newly formed secondary calli were transferred to half-strength MS containing 10 g/l sucrose, 3.6 ml/l glycerol, 8 g/l Noble agar amended with 25 mg/l kanamycin, 300 mg/l cefotaxime and 200 mg/l carbenicilin. After embryo differentiation, clumbs of globular and torpedo structures were transferred on MS with 20 g/l sucrose, 1 g/l casein hydrolysate and 3.6 ml/l glycerol supplemented with 25 mg/l kanamycin, 300 mg/l cefotaxime and 200 mg/l carbenicilin for hypocotyl elongation. Four months after transformation, elongated hypocotyls were transferred to WPM (McCown and Lloyd 1981) (Sigma-M6774, St. Louis, MO) containing 15 g/l sucrose, 3 g/l activated charcoal, 0.1 mg/l BAP and 6 g/l bactoagar (Sigma-A1296, St. Louis, MO) for plant regeneration (Krastanova et al. 2000) . Single embryo-derived plantlets were micropropagated on the same medium by subculturing apical cuttings to produce individual plants.
Molecular characterization of putative transgenic plants
Putative transgenic plants were identified based on their ability to grow on kanamycin-containing selection medium and by detecting the expression of the neomycin phosphotransferase II (NPTII) protein in double antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA) (5 0 -3 0 ). Presence of transgenes was characterized by polymerase chain reaction and Southern blot hybridization, respectively with total plant DNA isolated from leaves of greenhouse-grown plants as described previously (Lodhi et al. 1994) . For Southern blot hybridization, 20 lg of total DNA was digested with SacI (Promega, Madison, WI), resolved by electrophoresis on 1% (w/v) agarose gels in 19 Tris-borate buffer and blotted onto Nytran N filter (Schleicher and Schuell, Keene, NH) according to the manufacturer's instructions. Blotted DNA was fixed by baking at 80°C for 1 h. Prehybridization was performed for 2 h. Transgene insertion was detected by hybridization with a [a-32 P(dCTP)]-labeled virE2 gene probe, obtained using the RadPrime DNA labeling system (Gibco BRL, Gaithersburg, MD), as described (Sambrook et al. 1989 ).
Disease resistance assays
Plants of transgenic and non-transgenic lines were assayed for crown gall resistance using A. tumefaciens strains C58 (nopaline) and A6 (octopine), and A. vitis strain CG450 (vitopine) as inoculum. Bacterial inocula were grown at 28°C for 2 days on solid potato dextrose agar (PDA), suspended in sterile distilled H 2 O to an optical density of 0.1 at A 600nm which is approximately 1.0 9 10 8 cfu/ml, and diluted to a concentration of about 1.0 9 10 6 cfu/ml. Resistance assays were performed first in vitro with internode sections from greenhouse-grown plants over a period of four consecutive years. Internode sections, 7-10 mm in length, were submerged for 1 h in A. tumefaciens suspensions or sterile distilled water, and transferred on half-strength B5 medium (Gamborg et al. 1968) for 2 days in the dark. Then internode segments were transferred to half-strength B5 medium containing 200 mg/ml cefotaxime and the fungicide Bravo (chlorothalonil-weather stik, 720 mg/l) at 25°C with a 16 h photoperiod under cool fluorescent light at 54 lEm -2 s -1 . An average of 20 internode segments was tested for each transgenic line each year. Susceptibility to Agrobacterium was evaluated by visual observation of tumor formation at 14 and 21 days post-infection (dpi). Tumor size was determined based on the following disease index: no galls (0 mm), small galls (1-2 mm), medium galls (2-4 mm), large galls (4-6 mm) and very large galls ([10 mm). Controls included internode segments from non-transgenic plants that were inoculated with Agrobacterium strains or with sterile distilled water. Transgenic plants were scored as resistant if no galls developed or half or less of the total explants developed smaller galls that were 1-2 mm diameter.
Resistance assays were also carried out on plants grown in a greenhouse by inoculation with A. tumefaciens strains C58 and A. vitis strains TM4 and CG450 (Otten et al. 1996) for two consecutive years. Greenhouse tests focused on plants from transgenic lines that showed resistance in vitro. Plants were screened for resistance after acclimatization from tissue culture during the first year and after dormancy and growth until a 20-node development stage during the second year. Inoculations were made closely below nodes by stab wounding tissue with a pin (0.8 mm in diameter) dipped into bacterial growth on PDA (Pu and Goodman 1992) beginning five nodes below the tip of growth on actively growing plants. Susceptibility, based on gall development, was evaluated 2 months after inoculation. Gall size was measured by following the same disease index used in in vitro assays. Controls included non-transgenic plants inoculated with Agrobacterium strains or with sterile distilled water. Transgenic plants were scored as resistant if no galls developed after 2 months or if half or less of the inoculated nodes developed galls that were small in size (1-2 mm).
Results
Generation and characterization of transgenic plants
Embryogenic calli derived from anthers of grapevine rootstocks 110 Richter, 3309 Couderc and Teleki 5C were transformed with truncated virE2 sourced from A. tumefaciens strains C58 and A6, and A. vitis strain CG450. The virE2 expression cassette was contained in the pBIN19 binary vector backbone (Fig. S1 ). Putative transgenic plants were selected for further evaluation within 6-7 months following Agrobacterium-mediated transformation. About 322 putative transgenic lines were produced (33, 42 and 49 lines of 110 Richter; 20, 27 and 56 lines of 3309 Couderc; and 13, 39 and 43 lines of Teleki 5C with truncated virE2 constructs from A. tumefaciens strains C58, and A6, and A. vitis strain CG450, respectively) on the basis of their ability to regenerate on selection medium and detectable expression of the neomycin phosphotransferase II (NPTII) protein by DAS-ELISA. Only a very limited number of 110 Richter (4%, 5 of 124) and 3309 Couderc (3%, 3 of 103) lines were negative for NPTII in DAS-ELISA, indicating that the selection conditions to recover transformed plants were stringent. To confirm the transgenic status of test plants, the insertion of the virE2 constructs from Agrobacterium strains C58, A6 and CG450 was characterized by PCR and Southern blot.
Confirmation of T-DNA transfer and integration by PCR and Southern blot
About 295 lines of the three grapevine rootstock genotypes were analyzed by PCR with total plant DNA template and appropriate primers to detect the presence of truncated virE2 transgene. Overall, expected virE2 amplicons were obtained for 97% (285 of 295) of the transgenic lines tested by PCR, including all Teleki 5C lines. Only six transgenic lines of 3309 Couderc and four transgenic lines of 110 Richter that reacted positively for the NPTII protein in DAS-ELISA did not yield a virE2 amplicon. As illustrated for eight 110 Richter transgenic lines, a DNA amplicon of the expected size (1,020 bp) was obtained (Fig. S2) . No amplicon was obtained from DNA of non-transgenic plants (Fig. S2) . Selected PCR-positive putative transgenic plants were further analyzed to determine transgene insertion loci and copies of T-DNA/plant junction fragments by Southern blot hybridization of a virE2 probe from Agrobacterium strain C58 on SacIdigested plant DNA. As shown in Fig. S1 , SacI is a unique site in the T-DNA of all the three binary constructs and the distance between the SacI enzyme and right border (RB) is approximately 4 kb. Hence, the size of the right border junction fragment(s) is expected to be C4 kb. Plants of the seven transgenic 110 Richter lines tested showed insertion of the virE2 construct at one to three loci (Fig. 1) . As expected, the size of the virE2 hybridizing fragments were at least 4.4 kb for all the lines tested, except line 828 for which a shorter truncated right border junction fragment was observed in addition to the major insertion fragment (Fig. 1) .
Reaction of transgenic rootstocks to inoculation with three Agrobacterium strains
The susceptibility to crown gall of a subset of 154 transgenic lines was evaluated by in vitro inoculation of shoot internode explants with A. tumefaciens strains C58 and A6 and with A. vitis strain CG450. This subpopulation of transgenic plants represented half of the transgenic population produced. Nontransgenic controls consistently developed very large ([10 mm) size galls between 14 and 21 days postinoculation (dpi). Some transgenic lines exhibited resistance with half or less of the inoculated explants Fig. 1 Southern hybridization analysis of seven putative transgenic grapevine rootstock 110 Richter lines transformed with a pBIN19 binary plasmid encompassing truncated virE2 derived from A. tumefaciens strain C58. Genomic plant DNA was restricted with SacI, blotted onto a nylon membrane and hybridized with radio-labeled virE2 as the probe. Total DNA from a non-transformed plant was used as a control. Signals obtained indicated the right border T-DNA/plant junction fragment(s). The hybridization patterns showed an insertion of the virE2 construct at one to three loci. Lambda DNA digested with HindIII was used as the size marker developing galls. Of the 80 transgenic 3309 Couderc lines tested, ten were resistant to Agrobacterium infection (Table S1 ). Although the level of resistance varied among lines, resistance was observed for infection with both homologous and heterologous strains. For instance, transgenic line 46 expressing virE2-C58 showed an infection rate of 0, 15 and 20% when challenged with strains A6, C58 and CG450, respectively. Similarly, transgenic line 45 containing virE2-CG450 showed an infection rate of 2, 10 and 20% upon inoculation with strains C58, CG450 and A6, respectively. Interestingly, a higher level of resistance was achieved against the homologous Agrobacterium strain in majority of transgenic lines containing virE2-C58 and virE2-A6 (Table S1 ). In contrast, a higher level of resistance was obtained against the heterologous Agrobacterium strain C58 in transgenic lines containing virE2-CG450 (Table S1 ).
Of the 48 transgenic 110 Richter lines expressing virE2-C58 that were tested, seven lines exhibited resistance (Table 1) . These seven lines were confirmed by Southern analysis to contain one to three copies of the virE2 transgene (Fig. 1) . Resistance to crown gall disease was higher in transgenic lines challenged with the cognate Agrobacterium strain than with heterologous strains. For instance, transgenic line 7 expressing virE2-C58 showed a 7, 12 and 22% infection rate following inoculation with Agrobacterium strains C58, CG450 and A6, respectively. A similar pattern was observed for the six other independent transgenic lines tested (Table 1) . Of the 26 transgenic Teleki 5C lines screened for resistance to crown gall disease by in vitro inoculation assay, six were found to be resistant (Table 2) . Interestingly, no association was found between the level of resistance and the source strain of virE2 for this resistant genotype.
Transgenic grapevine rootstock lines with the highest level of resistance to Agrobacterium infection as revealed in the in vitro screening tests were further evaluated in the greenhouse for resistance by challenge inoculation with A. tumefaciens strain C58 and A. vitis strains TM4 and CG450 (Table 3 ). The objective of these experiments was to test whether resistance to Agrobacterium infection is manifested at the plant level. Two A. vitis strains were selected as inocula because our primary goal was to engineer practical resistance to the main causal agent of crown gall disease. All the VirE2-C58 expressing transgenic lines tested displayed significantly higher level of resistance to infection with the cognate strain C58 (Table 3) which was the source of virE2 transgene. However, the transgenic lines exhibited a relatively lower level of resistance upon infection with heterologous A. vitis strains TM4 and CG450 as shown by an increase in the percentage of explants forming galls (Table 3) . Transgenic 110 Richter lines 4, 6 and 828 were resistant to infection by the three Agrobacterium strains as well as transgenic 3309 Couderc lines 46 and 69 and Teleki 5C lines 6 and 11 (Table 3 ). In addition, plants of these resistant lines showed reduced gall size (1-6 mm) as shown for the 110 Richter line 828 (Fig. 2b) . These results confirm the observations documented from in vitro resistance screening assays with internode explants. Notwithstanding, transgenic 110 Richter lines 7, 536, 716 and 822 were resistant to A. tumefaciens but not to one or the two A. vitis strains (Table 3) . Overall, the level of resistance varied among transgenic lines and the percentage of transgenic plants that developed galls was significantly lower than those of non-transformed control (Table 3) . Moreover, the gall size was very large ([10 mm) in non-transformed control plants (Fig. 2c) which developed galls after 20 dpi. In contrast, transgenic plants showed signs of gall formation only after 30-35 dpi and their gall size was reduced (1-6 mm) (Fig. 2b) . Some of the transgenic lines such as 716 exhibited galls at a much later stage 40 days after inoculation with Taken together, our data clearly showed that resistance to crown gall disease can be achieved by expressing truncated virE2 constructs in grapevine rootstocks.
Discussion
Different strategies have been deployed to engineer resistance to crown gall disease in grapevines and other plants. Some examples include engineered resistance based on the expression of antimicrobial peptides in Vitis vinifera 'Chardonnay' (Vidal et al. 2006) , by expression of virE2 lacking the C-terminus single-stranded binding domain in tobacco (Citovsky et al. 1994) , antisense-mediated suppression of host factors associated with T-DNA trafficking, integration and cell transformation in Arabidopsis thaliana (Ward et al. 2002; Zhu et al. 2003) , silencing of oncogenes present in the T-DNA (Escobar et al. 2001 (Escobar et al. , 2002 and exogenous application of the phytohormone salicylic acid or its analogs before the onset of crown gall disease presents a possible means for achieving durable disease control (Anand et al. 2008) . The initial attempt to develop resistance to crown gall was by over-expressing a truncated virE2 (Citovsky et al. 1994) . Though the molecular mechanism underlying resistance mediated by a chimeric virE2 is unclear, it is hypothesized that the truncated VirE2 protein, devoid of a single stranded DNA-binding domain, competes with the wild type VirE2 of A. tumefaciens following infection for VirE2-interacting host factors essential for T-DNA transformation, such as VIP1 (Tzfira et al. 2001; Ward et al. 2002) and VIP2 (Anand et al. 2007) and possibly titrates them. Here, we reported a practical application of the virE2-mediated resistance in an economically important commercial crop such as grapevine. We generated transgenic grapevine rootstocks expressing a virE2 C-terminus deletion derivative from A. tumefaciens strains A6 and C58, and A. vitis strain CG450 and showed high level of resistance to crown gall disease in some of these transgenic lines. None of the transgenic grapevine rootstocks was immune to Agrobacterium infection except line 716 under the conditions used (Table 3) . Resistant transgenic lines showed various levels of gall development and their size was generally much reduced than those of non-transformed controls. Furthermore, gall formation was delayed by at least 15-20 days in transgenic lines when compared to nontransformed control plants. Resistance was expressed as reduction in both the number of plants showing tumors and gall size, confirming previous observations (Citovsky et al. 1994 ).
Molecular characterization of seven 110 Richter transgenic lines by Southern analysis revealed integration of virE2-C58 at one to three loci. These plants along with those harboring either virE2-A6 or virE2-CG450 displayed tumors of significantly reduced size than non-transformed controls in the in vitro resistance screening assays and inoculation tests in the greenhouse. In addition, tumors developed much earlier and at a faster rate in non-transformed control plants compared with transgenic plants. The level of resistance exhibited by transgenic 110 Richter lines harboring virE2-C58 was higher upon challenge inoculation with A. tumefaciens strain C58 than with heterologous strains A6, TM4 and CG450 (Tables 1,  3 ). However, transgenic line 828 displayed relatively higher level of resistance to inoculation with all the three strains (C58, CG450 and TM4) tested (Table 3) . Molecular analysis of transgenic line 828 showed a truncated right border junction fragment in addition to the expected full-length T-DNA copy. The presence of the truncated T-DNA copy raises the possibility that it might be linked to the broad-spectrum resistance observed in transgenic line 828. Similarly, two transgenic lines of Teleki 5C and 3309 Couderc were resistant to the three Agrobacterium strains used as inoculum, including the two A. vitis strains. Those lines displayed resistance to gall development under in vitro inoculation assays and greenhouse conditions. Resistance at the whole plant level was maintained for a period of two consecutive years. Interestingly, the gall size lowered over time. This observation is in contrast to the report by Vidal et al. (2006) where in larger gall size was observed in the second year compared with the first year.
The virE2 of A. tumefaciens strains exhibits significant sequence homology at the nucleotide and amino acid levels. In silico analysis of the virE2 nucleotide and amino acid sequence of strains A. tumefaciens strains C58 and A6 showed an identity of 70.6 and 67.8%, respectively (data not shown). Based on the similarity at the molecular level, we anticipated that virE2 derived from a given strain could confer resistance to gall formation incited by not only the cognate strain but also by heterologous strains. Our hypothesis was well supported by our results obtained with transgenic 110 Richter lines expressing VirE2-C58, which displayed resistance not only to challenge inoculation with cognate Agrobacterium strain C58, but also to A6 and A. vitis strain CG450. Our observation is in contrast to a previous study where transgenic tobacco expressing VirE2-C58 displayed resistance when challenged with the cognate A. tumefaciens strain C58 but developed tumors upon inoculation with A. tumefaciens strain A6 (Citovsky et al. 1994) . Taken together, it is evident from our results that truncated virE2 can be used to develop resistance to crown gall disease in grapevine where it is still a serious and persisting problem.
Lately, RNAi-mediated resistance is being employed to develop durable resistance in tree, nut and fruit crops, including grapevines. It is suggested to provide a broad-spectrum resistance to a wide-range of Agrobacterium biovars because of the highly conserved tumor-inducing hormone synthesis genes across species (Escobar et al. 2003; Viss et al. 2003) . With the current developments in the elucidation of Agrobacterium-plant interactions, new insights are gained into the infection mechanism of the bacterium, enabling the development of novel and effective strategies to control crown gall disease. The use of virE2 against the bacteria also has clear potential as a powerful and useful technology to engineer resistance to crown gall. Field tests of transgenic lines showing resistance need to be validated before commercialization of this technology can be realized.
